News for Xeris Pharmaceuticals, Inc. (XERS)

Published at

Jun 2, 2025 9:15 PM

by gurufocus.com

neutral

neutral

XERS: Key Highlights from Analyst and Investor Day | XERS Stock News

Xeris Pharmaceuticals, Inc. (XERS) is set to host its Analyst and Investor Day on June 3, starting at 10 a.m. This event will be accessible via a webcast.Wall S

XERS 0A8E.L

Read more →
Published at

Apr 17, 2025 1:23 PM

by manilatimes.net

positive

positive

Bright Peak Therapeutics Appoints John Schmid to its Board of Directors

**media[597926]**

XERS PSTX HLXA DSGN ANAB

Read more →
Published at

Mar 25, 2025 9:22 PM

by manilatimes.net

positive

positive

Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025

**media[576501]**

XERS

Read more →
Published at

Mar 5, 2025 6:46 PM

by seekingalpha.com

neutral

neutral

Xeris Pharmaceuticals Q4 2024 Earnings Preview (NASDAQ:XERS)

Discover what to expect as Xeris Pharmaceuticals (XERS) reports Q4 earnings on March 6th.

XERS

Read more →
Published at

Jan 21, 2025 4:00 PM

by gurufocus.com

positive

positive

The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and Awareness

PR NewswireCHICAGO and ARLINGTON, Va., Jan. 21, 2025 Strategic collaboration formed to raise awareness that all people with diabetes on blood glucose-lower

XERS

Read more →
Published at

Aug 9, 2024 1:39 PM

by investing.com

mixed

mixed

Earnings call: Xeris Biopharma sees 26% revenue surge in Q2 2024 By Investing.com

Earnings call: Xeris Biopharma sees 26% revenue surge in Q2 2024

XERS FRGAP 0A8E.L CHNGU

Read more →
Published at

Aug 7, 2024 5:03 PM

by seekingalpha.com

neutral

neutral

Xeris Pharmaceuticals Q2 2024 Earnings Preview (NASDAQ:XERS)

Xeris Pharmaceuticals (XERS) Q2 earnings results to be announced on August 8th.

XERS

Read more →
Published at

May 8, 2024 5:41 PM

by seekingalpha.com

neutral

neutral

Xeris Pharmaceuticals Q1 2024 Earnings Preview (NASDAQ:XERS)

Xeris Pharmaceuticals is set to announce Q1 earnings on May 9th.

XERS

Read more →
Published at

Mar 7, 2024 5:56 PM

by insidermonkey.com

positive

positive

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript

Operator: Hello everyone and welcome to the Xeris fourth quarter and full year 2023 financial results conference call and webcast. My name is Emily and I’ll be coordinating your call today.

XERS 0A8E.L

Read more →
Published at

Mar 7, 2024 3:22 PM

by investing.com

mixed

mixed

Earnings call: Xeris Biopharma reports robust growth and strategic refinancing By Investing.com

Earnings call: Xeris Biopharma reports robust growth and strategic refinancing

XERS FRGAP AMGN CHNGU

Read more →
Published at

Mar 6, 2024 1:03 PM

by seekingalpha.com

neutral

neutral

Xeris Pharmaceuticals GAAP EPS of -$0.10 in-line, revenue of $44.39M beats by $0.84M (NASDAQ:XERS)

Xeris Pharmaceuticals reports Q4 2023 financial results, beating revenue expectations.

XERS

Read more →
Published at

Mar 5, 2024 5:52 PM

by seekingalpha.com

neutral

neutral

Xeris Pharmaceuticals Q4 2023 Earnings Preview (NASDAQ:XERS)

Xeris Pharmaceuticals is set to announce Q4 earnings results, with expectations of a -$0.09 EPS and $43.55M revenue, based on upward revisions.

XERS

Read more →
Published at

Nov 10, 2023 10:00 PM

by insidermonkey.com

mixed

mixed

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q3 2023 Earnings Call Transcript

Operator: Hello, everyone and welcome to the Xeris Biopharma Third Quarter 2023 Financial Results Call. My name is Bruno. I'll be operating your call today.

XERS 0A8E.L

Read more →
Published at

Oct 25, 2023 1:26 PM

by globenewswire.com

neutral

neutral

Autoinjectors Market Size to Surpass USD 233.69 Billion by 2030, exhibiting a CAGR of 11.2%

According to the report by Fortune Business Insights, the global autoinjectors market size is projected to reach USD 233.69 billion by 2030, at a CAGR of...

XERS VTRSV VTRS.MX VTRS VIA.DE BDXB BDX.MX BDX 0R19.L 0A8E.L

Read more →
Published at

Jul 31, 2023 1:03 PM

by marketscreener.com

positive

positive

Xeris Ships One Millionth Gvoke® Unit

Updated guidelines recognize the benefits of ready-to-use glucagon Protecting all people with diabetes at risk of severe hypoglycemia remains the goal ...

XERS 0A8E.L

Read more →
Published at

Jan 30, 2023 1:26 PM

by markets.businessinsider.com

positive

positive

FDA Grants Orphan-drug Exclusivity For Xeris' Recorlev For Endogenous Cushing's Syndrome Treatment

(RTTNews) - Xeris Biopharma Holdings Inc. (XERS) said Monday that the U.S. Food and Drug Administration granted its subsidiary Xeris Pharmaceutica...

XERS 0A8E.L

Read more →
Published at

Sep 13, 2022 5:06 PM

by prnewswire.com

mixed

mixed

Global Bio-Pharma Market is Expected to reach USD 703.28 Billion by 2027 at 12.5% CAGR, Says Brandessence Market Research

/PRNewswire/ -- Global Bio-Pharma Market is valued at USD 274.10 Billion in 2020 and is expected to reach USD 703.28 Billion by 2027 with a CAGR of 12.5% over...

ZEG.DE XERS SBBP PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE MRKD.BA MRK.SN MRK.PA MRK.MX MRK GSK.L GSK GS7.DE GLAXF AZNN.MX AZNCF AZN.L AZN AMGN.MX AMGN.BA AMGN AMG.DE 6MK.DE 0A8E.L 0A4J.L ABBV34.SA ABBV.MX ABBV.BA ABBV 4AB.DE

Read more →
Published at

May 19, 2022 8:22 PM

by etfdailynews.com

mixed

mixed

Research Analysts’ Upgrades for May 19th (AAVMY, AAWW, AIT, AMOT, AMRN, AMZN, ATO, BCH, BCS, BECN)

Read Research Analysts’ Upgrades for May 19th (AAVMY, AAWW, AIT, AMOT, AMRN, AMZN, ATO, BCH, BCS, BECN) at ETF Daily News

ZLDPF ZEAL YUEIY YUEIF XGN WSFS VSSYW VS.CN VS VRTS VRSSF VOD UPST TUFN SWMAY SWMAF STEM.L SSMXY SSMXF SRNE SMAR SBG-UN SBG PRLB PFSI OWLT OSH OR OPGN OBSVN.MX OBSV OBSN.SW NICXF NEWT JMPLY JMPLF JMAT.L JEF.MX JEF ITCB ITAUCORP.SN HSBC.BA HSBC-PA HSBC HSBA.L HSB.PA HBCYF HBCN.MX HBC1.DE H1SB34.SA CSCO COX.PA BECN AMZN AAVMY 6869N.MX 6869.T 0RCQ.L 0L85.L 0KRR.L 0GO4.L 0A8L.L 0551.HK 0005.HK XERS X WPP UEPS UE UBSN.MX UBSGEE.SW UBSGE.SW UBSG34.SA UBSG.SW UBS TAC SYBX SGE.DE SCGLY SCGLF RPM ROP RMBS RCEL PSALL PSA.MX PSA-PQ PSA-PP PSA OSMT ORKLY ORKLF ORK.OL OLK OCUP NTCT NKTX NDRAW NDRA MMYT MKTW LPTX LNNGY LNNGF LANC KNYJY KNYJF KC4.DE JPMML JPM ISSDY ISFFF HE GSGI34.SA GS.MX GS.BA GS GOS.DE GLEN.MX GLE.PA FOJCY FOJCF FBIO EPR EA CTMX BCS BCH AVHHL AVH.AX ATO AMOT AIT ACND-UN ACND 2331N.MX 2331.HK 0A8U.L 0A8E.L DBN.MX DBK.PR DBK.MI DBK.DE DB

Read more →
Published at

May 19, 2022 5:32 PM

by etfdailynews.com

mixed

mixed

Xeris Biopharma (NASDAQ:XERS) Upgraded at Zacks Investment Research

Read Xeris Biopharma (NASDAQ:XERS) Upgraded at Zacks Investment Research at ETF Daily News

TRVC.DE C.MX C.BA C XERS 0A8E.L

Read more →
Published at

May 18, 2022 2:10 PM

by news.google.com

neutral

neutral

PDS Biotechnology Appoints Seasoned Business Development Executive Sanjay Zaveri as Senior Vice President, Business Development

PDS Biotechnology Appoints Seasoned Business Development Executive Sanjay Zaveri as Senior Vice President, Business Development - read this article along with other careers information, tips and advice on BioSpace

XERS SBBP PDSB

Read more →